Alkermes
ALKS
#3093
Rank
โ‚ฌ4.18 B
Marketcap
25,35ย โ‚ฌ
Share price
0.75%
Change (1 day)
-14.85%
Change (1 year)

Revenue for Alkermes (ALKS)

Revenue in 2025 (TTM): โ‚ฌ1.36 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.30 Billion. In 2024 the company made a revenue of โ‚ฌ1.49 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ1.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ1.36 B-8.89%
2024 โ‚ฌ1.49 B-0.52%
2023 โ‚ฌ1.50 B45.18%
2022 โ‚ฌ1.03 B0%
2021 โ‚ฌ1.03 B22.72%
2020 โ‚ฌ0.84 B-19.21%
2019 โ‚ฌ1.04 B9.28%
2018 โ‚ฌ0.95 B27.05%
2017 โ‚ฌ0.75 B6.2%
2016 โ‚ฌ0.70 B23.37%
2015 โ‚ฌ0.57 B12.95%
2014 โ‚ฌ0.50 B
2012 โ‚ฌ0.41 B71.49%
2011 โ‚ฌ0.23 B82.88%
2010 โ‚ฌ0.13 B2.02%
2009 โ‚ฌ0.12 B-48.11%
2008 โ‚ฌ0.24 B48.35%
2007 โ‚ฌ0.16 B-3.95%
2006 โ‚ฌ0.17 B51.05%
2005 โ‚ฌ0.11 B125.1%
2004 โ‚ฌ50.99 M81.97%
2003 โ‚ฌ28.02 M-38.43%
2002 โ‚ฌ45.51 M-21.71%
2001 โ‚ฌ58.13 M22.99%
2000 โ‚ฌ47.26 M91.21%
1999 โ‚ฌ24.72 M-36.47%
1998 โ‚ฌ38.91 M64.99%
1997 โ‚ฌ23.58 M52.89%
1996 โ‚ฌ15.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
โ‚ฌ99.34 M-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 3,057.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 5,957.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ53.92 B 4,027.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.92 B 3,720.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 1,002.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
โ‚ฌ70.16 M-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.81 B 3,023.90%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
โ‚ฌ48.41 B 3,605.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland